1st Jul 2008 17:54
1 July 2008
SYNERGY HEALTHCARE PLC ("the Company")
The Company has been notified that the following award of LTIP options have been made, pursuant to the LTIP scheme, to certain executive directors of the Company over 192,136 ordinary shares of 0.625p each in the Company ("Ordinary Shares"), as follows:
Director
|
Award
|
Share Price (p)
|
Richard Steeves (Chief Executive)
|
104,603
|
738.5
|
Ivan Jacques (Group Finance Director)
|
49,163
|
738.5
|
Marcello Smit (Chief Executive of Lips Textielservice)
|
38,370
|
738.5
|
In accordance with the LTIP scheme rules for conditional awards, the LTIP options were made based on a share price of 738.5 pence per Ordinary Share, being the closing price of an Ordinary Share as at 30 June 2008.
The LTIP options have been granted on a conditional basis and no shareholder rights will be conferred upon the grantee until the LTIP options have vested. Such vesting is subject to the achievement of the performance criteria of the scheme over the three year measurement period to 30 June 2011.
Furthermore, on 5 June 2008 Synergy Healthcare was notified that Dr Richard Steeves, Chief Executive and Mr Ivan Jacques, Group Finance Director, purchased 100,000 shares and 2,500 shares in the Company respectively. Both purchases were made at 710p per share.
Accordingly, on 30 June 2008 up to 59,420 and 5,000 matching shares were awarded under the LTIP Co-invest Options scheme to Dr Steeves and Mr Jacques respectively which will vest on 30 June 2011 subject to the terms of the scheme. The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-invest.
Enquiries
Ivan Jacques (Group Finance Director and Company Secretary) +44 (0) 1793 891 861
Related Shares:
SYR.L